TTK Healthcare Limited (BOM:507747)
1,141.55
-18.85 (-1.62%)
At close: Aug 17, 2026
TTK Healthcare Revenue
TTK Healthcare had revenue of 2.58B INR in the quarter ending June 30, 2026, with 13.75% growth. This brings the company's revenue in the last twelve months to 8.88B, up 8.34% year-over-year. In the fiscal year ending March 31, 2026, TTK Healthcare had annual revenue of 8.57B with 6.96% growth.
Revenue (ttm)
8.88B
Revenue Growth
+8.34%
P/S Ratio
1.82
Revenue / Employee
6.42M
Employees
1,384
Market Cap
16.13B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.57B | 557.88M | 6.96% |
| Mar 31, 2025 | 8.01B | 487.00M | 6.47% |
| Mar 31, 2024 | 7.53B | 276.84M | 3.82% |
| Mar 31, 2023 | 7.25B | 1.26B | 21.01% |
| Mar 31, 2022 | 5.99B | 1.23B | 25.88% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Hikal | 17.35B |
| Venus Remedies | 8.11B |
| Fredun Pharmaceuticals | 7.44B |
| Lincoln Pharmaceuticals | 7.03B |
| Kopran | 7.00B |
| Wanbury | 6.53B |
| Amrutanjan Health Care | 5.11B |
| Fermenta Biotech | 5.11B |
TTK Healthcare News
- 24 days ago - Wipro Consumer Care buys TTK’s Good Home, Eva brands for Rs 256 cr - The Times of India